RT @DrOlaLandgren: @SoMeCME Future considerations for CAR T: Determinants of response, eg, tumor, microenvironment, T-cell characteristics…
@SoMeCME Future considerations for CAR T: Determinants of response, eg, tumor, microenvironment, T-cell characteristics Mechanisms of resistance, eg, antigen heterogeneity/expression changes, tumor load, genomics, host immunity See additional details here
RT @BCD_AACR: @ESmithMDPhD, @BCD_AACR Scientific Editor, discusses #immunotherapy resistance. Check out recent review on mechanisms of resp…
RT @BCD_AACR: @ESmithMDPhD, @BCD_AACR Scientific Editor, discusses #immunotherapy resistance. Check out recent review on mechanisms of resp…
@ESmithMDPhD, @BCD_AACR Scientific Editor, discusses #immunotherapy resistance. Check out recent review on mechanisms of response and relapse to #CARTcell therapy in #myeloma. https://t.co/ZRijjZNfAO #IMS2022 https://t.co/cAEaFZ9Vrx
RT @CARTTherapy: Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/h5DplIHbTm #…
RT @CARTTherapy: Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/h5DplIHbTm #…
Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/h5DplIHbTm #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy @ASTCT https://t.co/uuvHw5QWQd
RT @PaperbirdsM: New article: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/…
New article: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/1UfB4txBH1 #MMSM #MultipleMyeloma #hematology https://t.co/5NLXHkaXDs
RT @oncologycro: Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/y7umc8SQvG
#ICYMI: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma. https://t.co/qjvugg3olP @amsterdamumc @LevineCancer @szusmani #mmsm #CARTcell https://t.co/a0gyo1vUBW
RT @CARTTherapy: Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/h5DplIHbTm…
Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/y7umc8SQvG
RT @CARTTherapy: Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/h5DplIHbTm…
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
RT @LYM_MM_CONNECT: Interesting overview by van de Donk et al. in @BCD_AACR of the determinants of response to #CARTcell therapy and the me…
RT @LYM_MM_CONNECT: Interesting overview by van de Donk et al. in @BCD_AACR of the determinants of response to #CARTcell therapy and the me…
Interesting overview by van de Donk et al. in @BCD_AACR of the determinants of response to #CARTcell therapy and the mechanisms of resistance after initial remission in pts with #MMsm #MedEd #hematology @szusmani https://t.co/joh42Umdea https://t.co/cp88z
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
#CellTherapy #mmsm @MichaelJSlade @dgermain21 @LabFehniger @DiPersioLab
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
RT @BCD_AACR: From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myel…
From the July issue: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma. https://t.co/HqFUCk1GOE @amsterdamumc @LevineCancer @szusmani #mmsm #CARTcell https://t.co/MCvuFNy9zt
Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/h5DplIHbTm #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy @ASTCT
Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/TfTnQaIPM4 https://t.co/BItRXzmaEw
New article: Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma https://t.co/VWMsKqfc1j #MMSM #MultipleMyeloma #hematology https://t.co/7ORR984K38
RT @_TanyaBondar_: Watching the sessions on CAR T cell therapies at #16ICML? Suggested reading: a recent review of CAR T cell response and…
Watching the sessions on CAR T cell therapies at #16ICML? Suggested reading: a recent review of CAR T cell response and resistance mechanisms in myeloma https://t.co/20KPN9ekpw https://t.co/47IwQIYGBi
RT @albertomussetti: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/0VythAqd9…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @MarcoLDavila: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/q0WYRke8Ve
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @albertomussetti: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/0VythAqd9…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @albertomussetti: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/0VythAqd9…
RT @albertomussetti: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/0VythAqd9…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/0VythAqd94 via @nuzzel
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @_TanyaBondar_: #AACRMDT21 Eric Smith talks about mechanisms of resistance to BCMA-targeted therapies and ways to overcome it, including…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
RT @BCD_AACR: Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multi…
Just published #OnlineFirst: A Review on determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma. @amsterdamumc @LevineCancer @szusmani #mmsm #CARTcell https://t.co/i5L5692jX8 https://t.co/F0flCGloWM
RT @_TanyaBondar_: #AACRMDT21 Eric Smith talks about mechanisms of resistance to BCMA-targeted therapies and ways to overcome it, including…
RT @_TanyaBondar_: #AACRMDT21 Eric Smith talks about mechanisms of resistance to BCMA-targeted therapies and ways to overcome it, including…
RT @BCD_AACR: Attending the #AACRMDT21 session on immunotherapy? Read this Review article on CAR T cells in #myeloma published in Blood Can…
RT @BCD_AACR: Attending the #AACRMDT21 session on immunotherapy? Read this Review article on CAR T cells in #myeloma published in Blood Can…
RT @_TanyaBondar_: #AACRMDT21 Eric Smith talks about mechanisms of resistance to BCMA-targeted therapies and ways to overcome it, including…
#AACRMDT21 Eric Smith talks about mechanisms of resistance to BCMA-targeted therapies and ways to overcome it, including dual-CART described in this article: https://t.co/bmXF1hUVBA See this @BCD_AACR review on CART response and resistance in myeloma: http
Attending the #AACRMDT21 session on immunotherapy? Read this Review article on CAR T cells in #myeloma published in Blood Cancer Discovery today: https://t.co/2UI3ILV1Q8 #mmsm https://t.co/1eVpqYsdpV
RT @MarcoLDavila: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/q0WYRke8Ve
RT @MarcoLDavila: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/q0WYRke8Ve
RT @MarcoLDavila: Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/q0WYRke8Ve
Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma https://t.co/q0WYRke8Ve